Lobular carcinoma in situ (LCIS) of the breast is a non-invasive neoplasm characterized by abnormal cell growth in the lobules of the breast. While it is not considered breast cancer, it is a marker for increased risk of developing invasive breast cancer in the future. Accurate coding with ICD-10 Code D05.00 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate surveillance and management.
ICD-10 Code D05.00 represents lobular carcinoma in situ of the unspecified breast, indicating the presence of abnormal lobular cells without invasion. This code is used in clinical documentation and billing when diagnosing patients with LCIS, which may require monitoring and preventive strategies due to its association with an elevated risk of invasive breast cancer.
Lobular carcinoma in situ of unspecified breast is a condition where abnormal cells are found in the lobules of the breast. It is not invasive but indicates a higher risk for future breast cancer. Medical attention is necessary for appropriate management and surveillance.
ICD-10 Code D05.00 is utilized in SOAP notes to document the diagnosis of lobular carcinoma in situ, aiding in the assessment of patient history, clinical findings, and treatment plans. It is relevant in both acute and chronic care settings for comprehensive patient management.
In SOAP notes, ICD-10 Code D05.00 connects subjective patient reports and objective clinical findings to a formal diagnosis of lobular carcinoma in situ. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of lobular carcinoma in situ may not require immediate intervention but necessitates careful monitoring and preventive strategies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D05.00 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate claims for services related to lobular carcinoma in situ.
| CPT Code | Description |
|---|---|
| 77067 | Mammography, bilateral, including computer-aided detection. |
| 88305 | Pathology examination of breast tissue. |
| 99214 | Established patient office visit, moderate complexity. |
Common Questions About Using ICD-10 Code D05.00 for Lobular carcinoma in situ of unspecified breast
What is lobular carcinoma in situ?
Lobular carcinoma in situ (LCIS) is a non-invasive condition where abnormal cells are found in the lobules of the breast. It is not cancer but indicates an increased risk for developing invasive breast cancer in the future.
How is lobular carcinoma in situ diagnosed?
LCIS is typically diagnosed through breast imaging, such as mammograms or MRIs, followed by a biopsy that confirms the presence of abnormal lobular cells.
What are the treatment options for lobular carcinoma in situ?
Management of LCIS often involves regular monitoring with imaging studies, genetic counseling, and discussions about preventive measures, including lifestyle changes or prophylactic surgery.
Is lobular carcinoma in situ a form of breast cancer?
No, lobular carcinoma in situ is not considered breast cancer. However, it is a marker for increased risk of developing invasive breast cancer later in life.
Clinical Notes
SOAP notes
DAP notes
AI medical notes